NCT00212628|CompletedPhase 3
Loading search results
Sponsor study identifier
interventional
444
1 country
9
Study Start
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThe purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
September 13, 2005
Actual (reported)September 21, 2005
Actual (reported)New fragility vertebral fracture
New clinical fracture, biochemical markers of bone turnover, height, mean bone mineral density of the lumbar spine (L2-4 BMD), lower back pain.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Chugoku Region Facility
Chugoku, Japan
Chubu Region Facility
Chūbu, Japan
Hokkaido Region Facility
Hokkaido, Japan
Hokuriku Region Facility
Hokuriku, Japan
Kanto Region Facility
Kanto, Japan
Kinki Region Facility
Kinki, Japan
Kyushu Region Facility
Kyushu, Japan
Project Leader, Development Planning
Ono Pharmaceutical Co., Ltd.
444 participants (actual enrollment reported by the registry).
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Shikoku Region Facility
Shikoku Region Facility, Japan
Tohoku Region Facility
Tōhoku, Japan
Last Updated
June 14, 2012
Record last verified: 2012-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: